User profiles for John Heiss
John HeissSurgical Neurology Branch, NINDS, National Institutes of Health Verified email at ninds.nih.gov Cited by 8127 |
Elucidating the pathophysiology of syringomyelia
JD Heiss, N Patronas, HL DeVroom, T Shawker… - Journal of …, 1999 - thejns.org
Object. Syringomyelia causes progressive myelopathy. Most patients with syringomyelia
have a Chiari I malformation of the cerebellar tonsils. Determination of the pathophysiological …
have a Chiari I malformation of the cerebellar tonsils. Determination of the pathophysiological …
[PDF][PDF] Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma
Primary CNS lymphoma (PCNSL) harbors mutations that reinforce B cell receptor (BCR)
signaling. Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, targets BCR signaling and is …
signaling. Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, targets BCR signaling and is …
Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular …
JD Heiss, E Papavassiliou, MJ Merrill… - The Journal of …, 1996 - Am Soc Clin Investig
Brain tumor-associated cerebral edema arises because tumor capillaries lack normal blood-brain
barrier function; vascular permeability factor (VPF, also known as vascular endothelial …
barrier function; vascular permeability factor (VPF, also known as vascular endothelial …
Root and spinal cord compression from methylmethacrylate vertebroplasty
Study Design. Case report and literature review. Objectives. Clinicians use methylmethacrylate
vertebroplasty to treat vertebral hemangiomas, metastases, and osteoporotic fractures. …
vertebroplasty to treat vertebral hemangiomas, metastases, and osteoporotic fractures. …
Childhood ataxia with diffuse central nervous system hypomyelination
…, PE Hauer, CR Kaneski, JD Heiss… - Annals of Neurology …, 1994 - Wiley Online Library
A significant number of patients with progressive leukodystrophy do not have a definitive
diagnosis. This report describes the clinical, morphological, and biochemical characteristics of …
diagnosis. This report describes the clinical, morphological, and biochemical characteristics of …
Symptomatic vertebral hemangiomas: treatment by means of direct intralesional injection of ethanol
JL Doppman, EH Oldfield, JD Heiss - Radiology, 2000 - pubs.rsna.org
PURPOSE: To describe the technique and results of injecting ethanol directly into symptomatic
vertebral hemangiomas. MATERIALS AND METHODS: Eleven patients with paraplegia (…
vertebral hemangiomas. MATERIALS AND METHODS: Eleven patients with paraplegia (…
Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain
MA Proescholdt, JD Heiss, S Walbridge… - Journal of …, 1999 - academic.oup.com
Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that also induces
vascular permeability and macrophage migration. VEGF expression is weak in normal adult …
vascular permeability and macrophage migration. VEGF expression is weak in normal adult …
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Nanotechnology is the design and assembly of submicroscopic devices called nanoparticles,
which are 1–100 nm in diameter. Nanomedicine is the application of nanotechnology for …
which are 1–100 nm in diameter. Nanomedicine is the application of nanotechnology for …
[HTML][HTML] Association of human herpesvirus-6B with mesial temporal lobe epilepsy
…, A Fogdell-Hahn, A Vortmeyer, JD Heiss… - PLoS …, 2007 - journals.plos.org
Background Human herpesvirus-6 (HHV-6) is a β-herpesvirus with 90% seroprevalence
that infects and establishes latency in the central nervous system. Two HHV-6 variants are …
that infects and establishes latency in the central nervous system. Two HHV-6 variants are …
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease
… John Heiss at NINDS, the NIH clinical center pharmacy, and other staff at the NIH clinical
center are participating in the execution of the clinical protocol. The NIH/NCATS Office …
center are participating in the execution of the clinical protocol. The NIH/NCATS Office …